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Cost effectiveness of community leg ulcer clinics:
randomised controlled trial
C Jane Morrell, Stephen J Walters, Simon Dixon, Karen A Collins, Louise M L Brereton, Jean Peters,
Charles G D Brooker
Abstract
Objectives: To establish the relative cost effectiveness
of community leg ulcer clinics that use four layer
compression bandaging versus usual care provided by
district nurses.
Design: Randomised controlled trial with 1 year of
follow up.
Setting: Eight community based research clinics in
four trusts in Trent.
Subjects: 233 patients with venous leg ulcers allocated
at random to intervention (120) or control (113)
group.
Interventions: Weekly treatment with four layer
bandaging in a leg ulcer clinic (clinic group) or usual
care at home by the district nursing service (control
group).
Main outcome measures: Time to complete ulcer
healing, patient health status, and recurrence of ulcers.
Satisfaction with care, use of services, and personal
costs were also monitored.
Results: The ulcers of patients in the clinic group
tended to heal sooner than those in the control group
over the whole 12 month follow up (log rank
P = 0.03). At 12 weeks, 34% of patients in the clinic
group were healed compared with 24% in the control.
The crude initial healing rate of ulcers in intervention
compared with control patients was 1.45 (95%
confidence interval 1.04 to 2.03). No significant
differences were found between the groups in health
status. Mean total NHS costs were £878.06 per year
for the clinic group and £859.34 for the control
(P = 0.89).
Conclusions: Community based leg ulcer clinics with
trained nurses using four layer bandaging is more
effective than traditional home based treatment. This
benefit is achieved at a small additional cost and could
be delivered at reduced cost if certain service
configurations were used.
Introduction
Complete healing of venous leg ulcers can take years
and recurrence is a problem.1 Patients experience pain,
affecting sleep, mobility, and quality of life.2–4 The
financial cost of venous disease in Britain has been
estimated at between £294m and £650m a year.5 6 Most
care for people with leg ulcers has been provided by
community nurses,7 who use numerous treatments,
although adequate information about their effect on
complete healing or quality of life is not available.6 8
A unique graduated four layer compression band›
aging system was pioneered at Charing Cross
Hospital9 and clinics in Riverside that used this system
achieved a healing rate of 69% of venous ulcers in 12
weeks.10 Estimates indicated that costs for clinics were
lower than for the previous care system.11 The
effectiveness, however, remained uncertain, and con›
cern was expressed that this uncontrolled study
provided the basis for the introduction of a new leg
ulcer service.12
A randomised controlled trial was undertaken to
compare the effect of four layer bandaging in a clinic
setting on healing of venous leg ulcers and health
status against the usual home based care provided by
district nursing services. The relative cost effectiveness
of the two interventions was also evaluated.
Patients and methods
Recruitment
The study was approved by appropriate ethics commit›
tees. Recruitment was from September 1994 to May
1995 in eight clinics (four urban, two suburban, two
semirural) in four community trusts in Trent. The
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inclusion criteria were a venous ulcer below the knee to
the foot that was present for at least 3 months and ability
to travel to the clinic. Patients were assessed by clinic
coordinators using Doppler ultrasound. Those with an
ankle brachial pressure index < 0.8 were excluded. The
nurses all adhered to the standardised clinic protocol. A
total of 233 patients provided written informed consent
(fig 1). A random assignment schedule and serially num›
bered, sealed, opaque allocation envelopes were
prepared in advance for each of the eight clinic sites.
Intervention
The intervention was weekly treatment in a leg ulcer
clinic. Clinic coordinators all completed a course on
management of leg ulcers (ENB N18) and additional
training days to practice applying four layer bandaging
(supervised by experienced practitioners). Treatment
adhered as closely as possible to the Charing Cross
bandaging technique.9 After healing, patients were
prescribed class 2 compression stockings and were
reviewed by the clinic coordinators every 3 months. For
the control group, as it was a pragmatic trial, nurses in
the home provided the patients’ usual treatment.
Outcomes and follow up
The primary clinical end point was time to complete
healing of all ulcers within the 12 month follow up
period. The nurses recorded the date of healing,
defined as re›epithelialisation of all ulcers. Secondary
end points were health status, time to first recurrence
of a healed ulcer, and the number of weeks the patients
were free from ulcers.
In the absence of disease specific measures,13 four
measures of self perceived health status were used to
cover all relevant dimensions of health: the 36 item
short form health survey (SF›36),14 the EuroQol (EQ),15
the McGill short form pain questionnaire (SF›MPQ),16
and the Frenchay activities index.17
Questionnaires were posted 12 weeks and 12
months after recruitment to collect data on health
status and satisfaction. Reminder questionnaires and
telephone calls were used for non›responders or
missing responses.
Economic evaluation and analysis
The economic analysis was undertaken from an NHS
perspective. Total estimated NHS costs per patient
were calculated by estimating the cost of treatment for
leg ulcers (staff time, materials, transport, and
overheads) and the cost of use of other health services
(general practitioner contacts and hospital). For the
control group data were collected for individual home
visits to produce a mean cost per home visit. For the
clinic group data on use of resources were available for
each clinic session but not on an individual basis. The
mean cost per attendance per patient was derived from
the total cost per session.
Data on the use of health services related to care of
leg ulcers were also collected by the postal follow up
questionnaires. Data on resources not related to
patients—for example, overheads—were collected from
service managers. All resources were valued at 1995
prices. Unit costs were taken, when possible, from the
local service providers or national data sources.18 19
Because of the skewed distributions of the cost data,
mean costs per patient for both groups were compared
by permutation tests and confidence intervals were cal›
culated by bootstrap methods,20 which work by resam›
pling from the observed data and thus make no
assumptions on distribution.
Statistical analysis
Sample sizes were calculated based on the expected
difference in rate of healing between the groups after
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Fig 1 Diagrammatic representation of sample size
Table 1 Baseline characteristics of patients recruited. Values are
numbers (percentages) of patients unless stated otherwise
Characteristic
Clinic group
(n=120)*
Home group
(n=113)†
Mean (SD) age (years) 73.8 (10.9) 73.2 (11.6)
Mean (SD) area of ulcer (cm2) 16.2 (28.9) 16.9 (40.8)
Mean (SD) occurrence of first ulcer (years) 14.2 (14.9) 12.9 (15.9)
Mean (SD) maximum duration of current ulcer
(months)
27.5 (53.8) 29.7 (82.3)
Mean (SD) body mass index (kg/m2) 27.0 (6.7) 27.1 (6.0)
Mean (SD) systolic brachial pressure (mm Hg) 154.8 (28.7) 153.9 (24.9)
Mean (SD) ankle brachial pressure index 1.08 (0.17) 1.10 (0.18)
Women 77 (64) 78 (69)
Married 56 (47) 52 (46)
Living alone 30 (25) 33 (29)
Walking with aid 66 (55) 57 (50)
Family history of leg ulcers 82 (28) 25 (22)
History of deep vein thrombosis 28 (23) 25 (22)
Varicose veins 77 (64) 76 (67)
Rheumatoid arthritis 14 (12) 18 (16)
Heart problems 13 (11) 8 (7)
Osteoarthritis 47 (39) 40 (35)
Diabetes mellitus 8 (7) 10 (9)
*Mean values measured in at least 110 patients.
†Mean values measured in at least 100 patients.
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12 weeks. To have an 80% chance of detecting as
significant (at the 5% level) an increase in healing from
50% to 70%, 206 patients were required.
All the data analysis was by intention to treat. We
used t tests or Mann›Whitney tests for continuous
measurements, ÷2 tests for categorical data, the
Kaplan›Meier method to calculate the time from
recruitment for the initial leg ulcer to heal, and the log
rank test to compare the healing times of both groups.
Previous work suggested that age, ulcer area, ulcer
duration, and history of deep vein involvement were
important factors in predicting time to healing.21 Cox
proportional hazards regression analysis was used to
adjust healing times for these variables.22 23 For each
dimension of the four measures of health status, we
calculated a summary measure of average health gain
per month for all patients as the area under the
response curve over the 12 months of follow up, meas›
ured with respect to the baseline score.24
Results
The patients in the two groups were well matched at
randomisation with respect to baseline clinical,
demographic, and health status measurements (tables
1 and 2). Various treatments were used in the control
group (table 3). Access to four layer bandaging for
patients in the control group was minimal as all
components were not available on prescription.25
There was evidence of a difference in the initial
healing times for leg ulcers between the groups over
the whole follow up (fig 2) with the clinic group tend›
ing to heal sooner (P = 0.03). The median healing times
were 20 and 43 weeks for patients in the clinic and
control groups, respectively. At 12 weeks the Kaplan›
Meier estimates of the cumulative percentages healed
at 12 weeks were 34% in the clinic group and 24% in
the control (difference 10%, 95% confidence interval
− 2% to 22%).
According to the Cox model the initial ulcer was
1.45 times more likely to heal in the clinic group than
in the control group (1.04 to 2.03). After adjustment
Table 2 Mean (SD) scores on measures of health status at
baseline by allocation to treatment in clinic or at home
Measure (range of scores)*
Clinic group
(n=120)†
Control group
(n=113)‡
SF›36 (0›100)
Physical function 41.8 (30.0) 45.0 (31.5)
Role limitation—physical 51.7 (42.5) 50.0 (40.1)
Pain 58.9 (28.9) 53.3 (28.4)
General health perception 66.8 (21.5) 62.4 (23.1)
Vitality 55.7 (19.3) 50.8 (23.8)
Social function 68.2 (30.0) 65.2 (31.2)
Role limitation—emotional 62.5 (43.1) 70.5 (40.3)
Mental health 71.7 (20.4) 67.6 (22.1)
EuroQol
Derived single index (0›100) 58.1 (16.7) 55.4 (19.0)
Frenchay
Frenchay activities index (15›60) 36.4 (9.9) 36.8 (10.4)
SF›MPQ
Pain rating index—sensory (0›33) 8.5 (7.2) 9.0 (6.7)
Pain rating index—affective (0›12) 2.0 (3.0) 1.9 (2.6)
No of words chosen (0›15) 5.4 (3.8) 5.6 (3.7)
Visual analogue scale:
Pain now (0›10) 3.1 (2.8) 3.1 (2.9)
Pain during day (0›10) 3.8 (2.8) 4.1 (3.0)
Pain at night (0›10) 4.2 (3.1) 4.3 (3.4)
*For SF›36, EuroQol, and Frenchay index high score indicates good health; for
SF›MPQ high score indicates greater pain.
†For SF›36 general health perception and vitality n=119.
‡For SF›MPQ pain rating index (sensory) and No of words chosen n=112.
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Fig 2 Healing times of initial leg ulcers by treatment group (solid
line=control group, n=113; dotted line=clinic group; n=120). Log rank
test statistic 4.90; df=1; P=0.03
Table 3 Range of treatments used by district nurses per visit in
control group
Treatment
No of
visits
No (%) of
times used
Wound preparation:
Normal saline 2114 1310 (62)
Water 381 42 (11)
Aqueous solution 243 17 (7)
Nothing 197 12 (6)
Normal saline and other 163 8 (5)
Aqueous solution and other 155 8 (5)
Other combination 158 8 (5)
Ulcer applications:
Non›adherent dressings 548 88 (16)
Alginate sheets 487 68 (14)
Non›adherent dressings and other 469 66 (14)
Hydrocolloid dressings 337 34 (10)
Hydrogel dressings 290 26 (9)
Paste bandages 184 9 (5)
Nothing 140 6 (4)
Paraffin gauze 115 3 (3)
Alginate sheets and other 99 3 (3)
Hydrocolloid or hydrogel dressings and other 92 3 (3)
Other combinations 650 124 (19)
Skin applications:
Nothing 1440 605 (42)
Liquid or soft white paraffin 512 77 (15)
Steroid cream 387 43 (11)
Aqueous cream 363 40 (11)
Lanolin free emulsifier 309 28 (9)
Other combinations 399 48 (12)
Securing agents:
Gauze padding 1007 302 (30)
Nothing 701 147 (21)
Simple tape 544 87 (16)
Gauze padding and simple tape 416 50 (12)
CrŒpe or crŒpe and other 415 50 (12)
Other combinations 328 33 (10)
Bandages:
Compression 1445 607 (42)
Tubigrip or Tubigrip and other 599 108 (18)
Compression and other 410 49 (12)
Light support or light support and other 334 33 (10)
None 270 22 (8)
Other combinations 352 35 (10)
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for the prognostic variables the initial healing rate of
clinic versus control patients was 1.65 (1.15 to 2.35).
In the clinic group, 35% (27/78) of patients who
initially healed had a recurrence against 23% (14/62)
in the control group. Some patients had several
episodes of recurrences and rehealing over follow up.
There was no evidence of a difference in the time to
first recurrence between the groups (log rank test 0.78;
df = 1; P = 0.38).
The mean time (in weeks) that each patient was free
from ulcers during follow up was 20.1 and 14.2 in the
clinic and control groups, respectively. On average,
patients in the clinic group had 5.9 more ulcer free
weeks (1.2 to 10.5) than control patients.
Health status and satisfaction
For most dimensions of the SF›36 and EuroQol, health
status deteriorated over time, with no difference
between the groups. For three dimensions of the
SF›MPQ there was evidence that the patients in the
clinic group were more likely to experience a reduction
in leg ulcer pain per month than control patients.
Satisfaction was high in both groups, but there were no
significant differences between the groups.26
Economic evaluation
Complete data on resource use were available for 66%
(214/323) of clinics and 62% (2110/3429) of recorded
home visits. From these data, the mean (SD) cost per
clinic attendance was estimated at £29.90 (£14.18),
while the mean (SD) cost per home visit was estimated
at £10.60 (£3.79).
The annual treatment cost was estimated for each
patient by using the mean cost per treatment, the mean
frequency of treatment, and patient specific data on
weeks with an active ulcer. The mean annual treatment
costs were £804.03 and £681.04 for the clinic group
and the control, respectively; a difference of £122.99
(£1.56 to £234.84). The control group reported greater
use of general practitioner and hospital services (table
4). When these NHS costs were combined with
treatment costs, treatment for the clinic group
remained £14.51 more expensive ( − £201.94 to
£214.25).
One way sensitivity analysis27 was undertaken to
investigate the effect that different assumptions might
have on mean costs. Changes in assumptions relating
to treatment costs and overheads in the control group
did not significantly affect the magnitude of costs (see
table 4). Weeks free from ulcers was the most appropri›
ate measure available for the cost effectiveness analysis.
The additional cost for the clinic group treatment
(£14.51) for achieving the benefit of 5.9 ulcer free
weeks gave an incremental cost effectiveness ratio of
£2.46 ( − £31.94 to £99.12) per ulcer free week.
Discussion
This subject is of economic importance, given the
reported high annual cost to the health service for leg
ulcer care.6 28 Although it was impossible to separate
the effect of four layer bandaging or of the specially
trained nurses from the clinic setting, the present study
pragmatically tested the “package” of care which was
already being used elsewhere.
The age distribution of the patients recruited was
similar to those reported elsewhere.9 10 29 30 The
baseline distributions of ulcer area and duration of
ulcers, however, were much greater than those
reported in other studies.10 29 30 Within the context of
other evidence on four layer bandaging the healing
rate in the clinic group (34%) was lower than the rates
reported as 74% and 69% in 12 weeks in dedicated
clinics.9 10 This probably reflects the larger areas and
longer duration of ulcers at baseline in this trial. The
nearest comparisons were described in two observa›
tional studies as 40% (of leg ulcers) in 12 weeks31 and
42% (of limbs) of people attending a leg ulcer clinic.32
The limitations for use of four layer bandaging in a
community clinic include the fact that some people are
unable to leave their home and cannot tolerate or do
not like the treatment.33 Patients have to accept the
additional time they must spend travelling and waiting
for and having treatment.
The outcomes of the SF›36 and EuroQol seemed
to show an overall deterioration in health status in both
groups and no improvement in the clinic group
associated with the superior healing rate. This could be
because the sample size was based on the expected dif›
ference in healing rates between the groups and not in
health status scores. Other possible explanations are
that the measures of health status were not sensitive
enough to detect the changes in health specific to the
condition or that the time points for follow up did not
coincide with the time when the patients improved.
The patients did have health problems apart from their
leg ulcer and some even died during the trial. Possibly
the impact of their leg ulcer was less than the impact of
their other health conditions and the tools were accu›
rately describing a deteriorating health status.
Economic evaluation
We undertook a modelling exercise to make the cost
results more applicable to the real world. Clinic coordi›
nators indicated that it was not necessary to use G or H
grade nurses for the service. Reanalysis of the data with
E grade salary costs gave a mean cost per clinic attend›
ance of £27.61 and an annual NHS cost of around
Table 4 Mean (SD) costs (£) per patient for use of all NHS services by group
Service Clinic group Home group
P value for
permutation test
Leg ulcer treatment/year 804.03 (535.92) 681.04 (391.70) 0.05
GP services/year 18.33 (67.14) 29.82 (102.62) 0.31
Hospital services/year 55.24 (319.71) 152.22 (680.96) 0.17
Total costs 877.60 (674.30) 863.09 (865.32) 0.90
Total costs (with increased overheads for
home visits)*
877.60 913.89
Total costs (with other treatments
excluded from home visits costs)†
877.60 788.17
Total costs (with 10% increase in home
visit costs)‡
877.60 931.19
Total costs (with 10% reduction in home
visit costs)‡
877.60 794.98
Total costs (with 10% increase in clinic
attendance costs)‡
958.00 863.09
Total costs (with 10% reduction in clinic
attendance costs)‡
797.20 863.09
*In baseline analysis no overheads were attributable to home visits as new working practices meant they
were expected to be small. Overheads from other work,18 believed to be much greater than for nurses in
this study, were used to estimate costs.
†Other treatments are sometimes given within home visits. To estimate cost of this work non›treatment time
was excluded from home treatment costs.
‡Mean cost estimates for home and clinic visits may be systematically biased because of missing data.
Possible effects of any bias investigated by adjustment of visit costs by +/−10%.
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£740 per patient. The restrictions on throughput
imposed by the trial produced an artificially high mean
cost per attendance at the start and end of the trial. We
estimated that by increasing throughput to more than
10 patients the mean cost per attendance could be
reduced to £24.87 and the annual NHS costs to
around £670 per patient. Altering both grade mix and
throughput produced a mean cost per attendance of
£23.37 and mean annual NHS costs of around £630
per patient (compared with £681 for traditional home
treatment). With either scenario, the clinic treatment
with four layer bandaging would dominate the home
based treatments, being both cheaper and more
clinically effective.
The mean cost per clinic attendance (£29.92) was
slightly more than the cost reported in Riverside
(£22.10 at 1995›6 prices).11 The modelling work
showed that small changes in the running of the clinics
gave a similar cost (£23.37 per attendance). The mean
cost per patient per year for clinic group patients in
this trial (£804.03) was more than the cost identified in
Riverside (£422 at 1995›6 prices). This difference could
be explained by the healing rates in the Riverside study
(80% of ulcers within 12 weeks).
Although the perspective of the economic evalua›
tion was the NHS, a societal perspective would have
included an account of patients’ time and personal
costs and loss of production due to treatment and poor
health. The relative costs may have changed with this
perspective as there were greater time costs for the
patients in the clinic group.
This trial did not show the impressive healing effects
reported in the early studies with four layer bandag›
ing,9 10 but overall the clinic healing rates improved on
care provided by the district nursing service. The
improved clinical outcomes were achieved at a small
incremental cost to the NHS. If the conditions of nurse
grade and throughput per session were optimised, the
clinic treatment with four layer bandaging would be
more clinically effective and less costly for community
trusts than treatment in the home.
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Key messages
+ Leg ulcer clinics based in the community using
four layer compression bandaging can be more
clinically effective than usual care provided by
the district nursing service
+ Community based leg ulcer clinics could be
provided more cost effectively than usual home
based care for venous leg ulcers
+ Recurrence of venous leg ulcers is an important
variable that should be measured in future trials
of venous leg ulcer care
+ It is difficult to measure improvements in health
related quality of life among people with
venous leg ulcers
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